Cabaletta Bio (CABA) saw its stock rise on Thursday, driven by notable insider buying activity. Michael Gerard, the company's General Counsel, acquired 6,600 shares for $14,979. Additionally, Chief Medical Officer Chang David J. purchased 8,800 shares at $2.26 each, while President of Science & Technology Binder Gwendolyn bought 11,312 shares at an average of $2.1891. These transactions highlight a significant vote of confidence from the company's leadership.
https://www.gurufocus.com/news/8543232/cabaletta-bio-caba-shares-surge-11-after-insider-buying
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.